CBPM

RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals

Retrieved on: 
Friday, March 1, 2024
CBPM, USD, Amend, Sale, RPK, Medicine, LDA, Patient, CBD, THC, Akanda, Schedule 2, Resolution

This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.

Key Points: 
  • This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.
  • Under the terms of the Share Purchase Agreement, Somai will acquire RPK, Akanda's indirect Portuguese subsidiary, for a total consideration of Two Million United States Dollars (USD $2,000,000).
  • The execution of the Share Purchase Agreement and Escrow Agreement follows the Amended Non-Binding Letter of Intent ("LOI") announced on February 1, 2024, and represents a crucial step towards the transaction's completion.
  • The closing of the proposed sale is subject to customary due diligence, representations, warranties, covenants, indemnities, and other closing conditions.

Lithium Ionic Appoints Chief Operating Officer to Advance the Development of the Bandeira Lithium Project, Minas Gerais, Brazil

Retrieved on: 
Monday, December 4, 2023
Lithium, Anglo American, Engineering, TSX Venture Exchange, Business, Mining, AMG, Mining engineering, Personality, LTH, Business administration, UFMG, FDC, CBPM, Head, Bandeira, Tantalum, EV

TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. ( TSXV: LTH; OTCQX: LTHCF; FSE: H3N ) (“Lithium Ionic” or the “Company”) is pleased to announce the appointment of mining veteran, Mr. Paulo Guimarães Misk, as Chief Operating Officer to lead the development of the Bandeira Lithium Project (“Bandeira” or the “Project”), in Minas Gerais State, Brazil.

Key Points: 
  • TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. ( TSXV: LTH; OTCQX: LTHCF; FSE: H3N ) (“Lithium Ionic” or the “Company”) is pleased to announce the appointment of mining veteran, Mr. Paulo Guimarães Misk, as Chief Operating Officer to lead the development of the Bandeira Lithium Project (“Bandeira” or the “Project”), in Minas Gerais State, Brazil.
  • As an industry leader, Mr. Misk will strengthen the Company’s executive team and its technical and operational capabilities as it quickly accelerates the Bandeira project.
  • During his tenure, he implemented innovative policies and fostered a high-performance culture that greatly improved the profitability of the operation.
  • Here he was responsible for the Tantalum and Niobium division and overall mining activities in Brazil, including the development of its Mibra lithium mine located in Minas Gerais State.

Cantourage UK Partners with Portocanna to Improve Affordable Medical Cannabis Access in the UK

Retrieved on: 
Friday, June 16, 2023
Partnership, Way, CBPM, Genetics, Consistency, Channel, Certification, Philosophy, Patient, Cannabis, Quality control, Entrepreneurship, Drug, Pharmaceutical industry, EU

LONDON, June 16, 2023 /PRNewswire/ -- Leading London-based medical cannabis company Cantourage UK and Portugal-based manufacturer Portocanna have announced an exclusive partnership. This collaboration aims to deliver affordable high-quality CBPM's to patients in the UK, fulfilling an important unmet need in the market.

Key Points: 
  • The Partnership Paves the Way for Consistent, High-Quality Affordable Medical Cannabis Supply for Patients
    LONDON, June 16, 2023 /PRNewswire/ -- Leading London-based medical cannabis company Cantourage UK and Portugal-based manufacturer Portocanna have announced an exclusive partnership.
  • Joshua Cuby, Co-Founder & Chief Sales Officer of Cantourage UK stated "In Cantourage UK, our focus has always been on delivering quality, consistent genetics and CBPMs.
  • "We trust Cantourage UK to enable us to fulfil our vision of consistent, reliable access to top-grade medical cannabis products for patients."
  • This collaboration between Cantourage UK and Portocanna will play a pivotal role in shaping the UK's medical cannabis landscape, securing more reliable access to quality medical cannabis for UK patients.